Guardian Pharmacy Services, Inc.

GRDN Healthcare Medical Care Facilities

Guardian Pharmacy Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 17.9% from fiscal 2024.

Revenue
−1.68%
EPS
+133.3%
Free cash flow
+88.9%

Quarter to September 2026, against a year earlier

39.72 2.37 −5.63%
Market cap
$2.5B
P/E
37.8×
Fwd P/E
33.3×
Dividend yield
—
F-score
7/9
Altman Z
10.28
Beneish M
−2.95
Dividend safety
n/a

Guardian Pharmacy Services, Inc. (GRDN) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Guardian Pharmacy Services, Inc. (GRDN) trades at a P/B ratio of 9.0×. Over the past ten years it has ranged from 0.0× (September 2024) to 11.8× (June 2026); the current reading is higher than 41% of that period. That is above the Medical Care Facilities industry median of 3.1× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 8.6× 2.84%
FY2024 8.4× —
FY2023 0.0× —

Quarterly newest first

Period P/B ratio Change
Sep 2026 9.2× (10.29%)
Jun 2026 10.3× 0.31%
Mar 2026 10.3× 19.11%
Dec 2025 8.6× 3.34%
8 more quarters

Against its own ten years

Low 0.0× High 11.8×
Ten-year median 9.2×
Current reading's percentile 41

P/B ratio against peers

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on GRDN